title: Protective role of unconjugated bilirubin on complement-mediated hepatocytolysis.
abstract: Hyperbilirubinemia and complement-mediated immune attack on hepatocyte membrane are common features of certain hepatic diseases. To assess whether unconjugated bilirubin (UB) counteracts complement-mediated hepatocytolysis, we first generated a rabbit polyclonal antibody (Ab) against rat hepatocyte plasma membrane (RHPM). An assay performed with isolated rat hepatocytes in the presence of the polyclonal Ab and rat serum as complement donor demonstrated that UB inhibits cell lysis, as lactate dehydrogenase release into the medium was inhibited by the pigment in a dose-dependent manner. Immunofluorescence microscopy studies showed that UB significantly attenuates the binding of C3 to the hepatocyte-Ab complex. Further enzyme immunoassay studies showed that UB interferes the binding of C1q to purified anti-RHPM IgG, also in a dose-dependent manner. A dot-blot assay showed that [14C]-UB binds to C1q and human serum albumin (HSA) to a similar extent. A differential spectrum analysis of UB in the presence of C1q further confirmed that the pigment interacts with this protein. In conclusion, we demonstrated an inhibitory action of UB on complement-mediated Ab-induced hepatocytolysis, this action being evidenced at pathophysiological pigment concentrations (171 microM and higher). A direct binding of the pigment to C1q is likely involved.
authors: Instituto de Fisiología Experimental, Facultad de Ciencias Bioquímicas y Farmacéuticas; CONICET-Universidad Nacional de Rosario, Rosario, Argentina.
authors: Cecilia L
authors: CL
authors: Basiglio
authors: Sandra M
authors: SM
authors: Arriaga
authors: Héctor F
authors: HF
authors: Pelusa
authors: Adriana M
authors: AM
authors: Almará
authors: Marcelo G
authors: MG
authors: Roma
authors: Aldo D
authors: AD
authors: Mottino
mesh_terms: D000818:Animals; D000906:Antibodies / Q000276:immunology; D001663:Bilirubin / Q000378:metabolism / Q000494:pharmacology*; D002462:Cell Membrane / Q000187:drug effects* / Q000276:immunology; D002478:Cells, Cultured; D015922:Complement C1q / Q000276:immunology / Q000378:metabolism*; D003169:Complement Inactivator Proteins / Q000494:pharmacology*; D004306:Dose-Response Relationship, Immunologic; D022781:Hepatocytes / Q000187:drug effects*; D007124:Immunoenzyme Techniques; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008297:Male; D008856:Microscopy, Fluorescence; D051381:Rats; D017208:Rats, Wistar
chemical_list: D000906:Antibodies; D003169:Complement Inactivator Proteins; D015922:Complement C1q; D007770:L-Lactate Dehydrogenase; D001663:Bilirubin